Sen. Bernie Sanders’ aggressive targeting of Danish drugmaker Novo Nordisk’s Ozempic and Wegovy pricing, and not Eli Lilly’s ...

Compounding pharmacies have increasingly been at the centre of safety concerns around the legitimacy and credibility of ...

Sima Sistani, CEO of WeightWatchers, announced her departure from the weight-loss company, which has struggled to adapt in ...

It’s similar with multiple sclerosis. Actually, there are so many good drugs out there. A lot of the market has already been ...

Semaglutide for obesity was associated with superior weight reduction and glycemic control among patients with obesity and prediabetes.